Mondadori C, Möbius H J, Borkowski J
Pharmaceutical Research Department, CIBA Ltd., Basel, Switzerland.
Behav Brain Res. 1996 May;77(1-2):223-5. doi: 10.1016/0166-4328(95)00222-7.
The memory-enhancing effects of a single treatment with the GABAB antagonist CGP 36,742 (10 mg/kg) or the nootropic agent oxiracetam (100 mg/kg) given immediately after a learning experience ('post-trial') remain detectable for at least 4 months thereafter. This indicates that in all probability these substances facilitate the formation of the long-term memory trace.
在学习经历后即刻(“试验后”)单次给予GABAB拮抗剂CGP 36,742(10毫克/千克)或益智药奥拉西坦(100毫克/千克)的记忆增强作用,在此后至少4个月内仍可检测到。这表明很可能这些物质促进了长期记忆痕迹的形成。